drugset / Trial / NCT05926258

Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population

NCT05926258

Phase 3 Completed 74 enrolled Sintetica SA Cross Research S.A. · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to assess the efficacy and safety of Chloroprocaine 3% eye gel compared to Oxybuprocaine 0,4% eye drops when used for inducing ocular surface anesthesia in pediatric patients. 74 Participants (male and female, aged 0-17 yrs) will be 1:1 randomized for receiving either the test drug (Chloroprocaine) or the reference drug (Oxybuprocaine) before undergoing to ocular exam who needs ocular surface anesthesia. The successful surface anesthesia will be evaluated 5 minutes after receiving 2 drops (1 minute apart) of either test or reference drug by an eye spear sponge

Timeline

Start
2024-05-23
Primary completion
2025-03-13
Completion
2025-03-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benoxinate Small molecule 4 mg/ml Topical
Subject Chloroprocaine Other / unclassified 3 % Topical

Indications

No indication recorded.